Jan 10 (Reuters) - Insmed Inc :
* INSMED PROVIDES BUSINESS UPDATE AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
* INSMED INC: NARROWING TIMING FOR EXPECTED U.S. LAUNCH FOR BRENSOCATIB IN BRONCHIECTASIS TO Q3 OF 2025
* INSMED INC: 2025 GLOBAL ARIKAYCE REVENUES EXPECTED TO BE BETWEEN $405 MILLION AND $425 MILLION
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.